XML 29 R19.htm IDEA: XBRL DOCUMENT v3.25.0.1

Common Stock, Stock Options and Warrants (Tables)

3 Months Ended

Dec. 31, 2024

Common Stock, Stock Options and Warrants [Abstract]

Schedule of Option Activity Under Our Stock Option Plans

A summary of option activity under our stock option plans (excluding the NoveCite and Citius Oncology Stock Plans) is presented below:

		Option Shares				Weighted- Average Exercise Price				Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding at September 30, 2024			656,084			$	36.41			7.26 years		$	0.00
Granted			185,000				9.50
Exercised			-				-
Forfeited or expired			-				-
Outstanding at December 31, 2024			841,084			$	30.49			7.63 years		$	0.00
Exercisable at December 31, 2024			502,184			$	40.62			6.57 years		$	0.00

A summary of option activity under the Citius Oncology plan is presented below:

		Shares				Weighted- Average Exercise Price				Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding at September 30, 2024			12,750,000			$	2.15			8.78 years		$	0.00
Granted			5,750,000				1.07
Forfeited			—
Outstanding at December 31, 2024			18,500,000			$	1.81			8.97 years		$	470,000
Exercisable at December 31, 2024			4,750,000			$	2.15			8.52 years		$	0.00

Schedule of Exercise of Outstanding Warrants

The Company has reserved 3,458,937 shares of common stock for the exercise of outstanding warrants. The following table summarizes the warrants outstanding at December 31, 2024:

		Exercise price				Number				Expiration Dates
August 2018 Offering Investors			28.75				156,863			August 14, 2025
August 2018 Offering Agent			39.84				7,576			August 8, 2025
April 2019 Registered Direct/Private Placement Investors			35.50				51,780			April 5, 2025
April 2019 Registered Direct/Private Placement Agent			48.28				9,605			April 5, 2025
September 2019 Offering Investors			19.25				111,732			September 27, 2025
September 2019 Offering Underwriter			27.97				7,774			September 27, 2025
February 2020 Exercise Agreement Placement Agent			31.88				5,555			August 19, 2025
May 2020 Registered Direct Offering Investors			25.00				66,824			November 18, 2025
May 2020 Registered Direct Offering Placement Agent			33.20				6,226			May 14, 2025
August 2020 Underwriter			32.81				8,079			August 10, 2025
January 2021 Registered Direct Offering Investors			30.78				123,648			July 27, 2026
January 2021 Registered Direct Offering Agent			40.44				14,065			July 27, 2026
February 2021 Offering Investors			42.50				823,211			February 19, 2026
February 2021 Offering Agent			47.03				100,256			February 19, 2026
May 2023 Registered Direct Offering Investors			37.50				500,000			May 8, 2028
May 2023 Registered Direct Offering Agent			37.50				35,000			May 3, 2028
April 2024 Registered Direct Offering Investors			18.75				857,143			October 30, 2029
April 2024 Registered Direct Offering Agent			21.875				60,000			April 25, 2029
November 2024 Offering Investors			6.25				480,000			November 18, 2029
November 2024 Offering Agent			7.8125				33,600			November 15, 2029
							3,458,937

Schedule of Common Stock Reserved for Future Issuances

A summary of common stock reserved for future issuances by the Company excluding all subsidiaries as of December 31, 2024 is as follows:

Stock plan options outstanding			841,084
Stock plan shares available for future grants			118,000
Warrants outstanding			3,458,937
Total			4,418,021

X

- Definition

Summary of common stock reserved for future issuances.

+ References

No definition available.

+ Details

Name:	ctxr_ScheduleOfCommonStockReservedForFutureIssuancesTableTextBlock
Namespace Prefix:	ctxr_
Data Type:	dtr:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration